Been out all afternoon and just saw the trading today, looks very good in a day when the overall market did nothing.
Appears to be a breakout of the "sloping wedge" formation. lol Wanelad what do the charts say?
Cant really guess re a licensing deal all I know is what the comparative valuation of comparable assets have traded for in the past and even discounting a fair bit for lack of US regulatory approval there's substantially more upside here.
Asset value of GBI is $1.50-$2.00 in my view and you never know what it could be if a competitive auction happens for the company. Touch wood we see a Vision Biosystems scenario.
Sonic are an end user customer not a prospective licensing partner. A prospective licensing partner would sell Paptype to the pathology labs like Sonic, GBI have just dealt direct with them which is all good.
Rgds
Prof
GBI Price at posting:
90.0¢ Sentiment: Buy Disclosure: Held
